Today: November 24, 2017, 3:24 am
  
Business

Market Dynamics to Escalate Demand for Dengue Vaccine Market Throughout 2017 - 2027

Dengue Vaccine Market
Dengue Vaccine Market
Future Market Insights has announced the addition of the “Dengue Vaccine Market : Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering.

 

PR-Inside.com: 2017-11-14 14:06:28
Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving to develop a cure for dengue, the fever’s incidence rate in Asia-Pacific is rising at an alarming rate. A recent report published by Future Market Insights predicts that in 2017, an estimated 70.3% of global dengue vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be the largest market for dengue vaccines, procuring a majority revenue share and projecting revenue growth at a 17.4% CAGR.


Future Market Insights also observes Latin America as the second-largest market for dengue vaccines, and is expected to rake in US$ 288.7 Mn towards the end of 2027. The report, titled “Dengue Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” expects that more and more pharmaceutical giants from across the globe will be partaking in the market’s growth in the years to come. Currently, the market is witnessing active participation of French drugmaker, Sanofi S.A., while vaccines being formulated by companies such as Biological E. Limited, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Merck & Co. Inc., Vabiotech, Butantan Institute, and Panacea Biotech Ltd. are under multiple phases of development.

Request to View Sample Report @ www.futuremarketinsights.com/reports/sample/rep-gb-1763

The report further reveals that government institutes will remain the largest end-users of dengue vaccines in the world. Through 2027, a little less than US$ 650 Mn worth of revenues is expected to arise from sales of dengue vaccines across government institutes. Meanwhile, hospitals will also dominate the market by registering a 17.3% revenue CAGR. The market, at present, will witness sales of the sole of vaccine, Dengvaxia, developed by Sanofi. Furthermore, factors shaping up the dynamics of global dengue vaccines market, also compiled in the report, are: Apart from the burdening outbreak of dengue in several countries, the economic turmoil in Latin America is projected to impact the global market’s growth at a macroeconomic level

Request For Table Of Content @ www.futuremarketinsights.com/toc/rep-gb-1763

Live attenuated vaccines are being developed & produced economically, thereby comforting vaccine makers as well as patients

However, lack of skilled professionals and unavailability of optimum diagnostic systems has given rise to cases where dengue fever is being treated as an undistinguished febrile disease

The global market for dengue vaccines holds an opportunistic breakthrough when drugmakers will be able to successfully develop effective vaccines for all age group

Buy Dengue Vaccine Market Research Report @ www.futuremarketinsights.com/checkout/1763

Press Information
future market insights
616 Corporate Way, Suite 2-9018, Valley Cottage,NY




email


Published by
Abhishek Budholiya
+1-347-918-3531
e-mail
www.futuremarketinsights.com



# 444 Words
Related Articles
More From The Author
Market Insights on Growth of Smart Insulin [..]
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development [..]
Growth Prospects of Global Aircraft Refurbishing Market [..]
Future Market Insights’ recently published report on global market for aircraft refurbishing projects that during a forecast period [..]
Growth Prospects of Global Automotive Wheel Coating [..]
Economic crisis observed in multiple parts of the world is being cited as a key restraint for sales of automotive [..]
Growth Prospects of Varicose Vein Treatment Market [..]
Varicose Vein Treatment Market Registering a Robust growth at 6.4% CAGR Through 2016-2026 Future Market Insights recently conducted [..]
Discover the Growth of the Atrophic Gastritis [..]
Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular [..]
 
More From Business
SEMAFO Mourns Passing of Board Chairman Jean [..]
MONTREAL, Nov. 23, 2017 (GLOBE NEWSWIRE) -- SEMAFO (TSX:SMF) (OMX:SMF) announces with sadness the passing of Mr. Jean Lamarre, Chairman [..]
Premier to join industry leaders at BDA [..]
HAMILTON, Bermuda, Nov. 23, 2017 (GLOBE NEWSWIRE) -- Premier David Burt will join more than two-dozen Bermuda executives in a [..]
ATOS : The Atos Quantum Programme Scientific [..]
Paris, 23 November 2017 - Atos, a  global leader in digital transformation, today held the Scientific Council of "Atos Quantum", [..]
G4S plc UK DK : AMAG's seamless [..]
  Yale University, one of the world's best known and oldest Ivy League institutions, has carried out - almost unnoticed [..]
Crown Bioscience and Data Sciences International (DSI) [..]
SANTA CLARA, Calif., Nov. 23, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.